|
Aug 7
|
We Think Merus (NASDAQ:MRUS) Can Afford To Drive Business Growth
|
|
Aug 6
|
Merus to Present at the Canaccord Genuity 45th Annual Growth Conference
|
|
Aug 5
|
Merus N.V. (MRUS) Reports Q2 Loss, Misses Revenue Estimates
|
|
Aug 5
|
Merus Announces Financial Results for the Second Quarter 2025 and Provides Business Update
|
|
Aug 4
|
Merus N.V. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Jun 5
|
Why Merus N.V. (MRUS) Crashed On Wednesday
|
|
Jun 4
|
Merus N.V. Announces Pricing of Public Offering of Common Shares
|
|
Jun 3
|
Merus N.V. Announces Proposed Public Offering of Common Shares
|
|
May 22
|
Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC
|
|
May 8
|
Merus to Present at BofA Securities 2025 Health Care Conference
|
|
May 7
|
Merus N.V. (MRUS) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 7
|
Merus Announces Financial Results for the First Quarter 2025 and Provides Business Update
|
|
May 7
|
Earnings Preview: Merus N.V. (MRUS) Q1 Earnings Expected to Decline
|
|
Apr 18
|
Is Merus (NASDAQ:MRUS) the Best High Short Interest Stock to Buy Now?
|
|
Feb 13
|
Merus to Present at Citi's 2025 Virtual Oncology Leadership Summit
|